Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 EX-3.1
- 3.2 EX-3.2
- 3.3 EX-3.3
- 3.4 EX-3.4
- 3.5 EX-3.5
- 4.1 EX-4.1
- 4.2 EX-4.2
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 10.18 EX-10.18
- 10.19 EX-10.19
- 10.20 EX-10.20
- 10.21 EX-10.21
- 10.24 EX-10.24
- 21.1 EX-21.1
- 23.1 EX-23.1
MRSN similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
Consent of independent registered public accounting firm
We consent to the reference to our firm under the caption "Experts" and to the use of our report dated March 17, 2017, in the Registration Statement (Form S-1) and the related Prospectus of Mersana Therapeutics, Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP | ||
Boston, Massachusetts May 31, 2017 |
Consent of independent registered public accounting firm